IMPACT OF SURFACE-ASSOCIATED VIRULENCE FACTORS ON THE CYTOTOXICITY OF ACINETOBACTER BAUMANNII OUTER MEMBRANE VESICLES

Danas Ivanauskas1, Jūratė Skerniškytė1

1 Vilnius University, Life Sciences Center, Institute of Biosciences, Department of Biochemistry and Molecular Biology, Vilnius, Lithuania

Acinetobacter baumannii is an opportunistic pathogen notable for its high levels of antibiotic resistance and its role in hospital-acquired infections [1]. Carbapenem-resistant A. baumannii was designated a top priority for antibiotic development by the WHO in 2017 [2]. Despite the identification of some virulence factors, the mechanisms underlying its pathogenicity remain poorly characterized compared to other Gram-negative bacteria [3]. It is known that A. baumannii releases outer membrane vesicles (OMVs) – nanoscale, outer-membrane-derived particles. OMVs are lipid bilayer vesicles released into the extracellular environment, containing outer membrane lipids and proteins, periplasmic enzymes, genetic material [4]. OMVs play an important role in pathogenesis by delivering virulence factors, inducing inflammation, promoting immune evasion and antibiotic resistance. By enabling host damage without direct bacterial contact, OMVs significantly enhance A. baumannii virulence [5]. This study aims to evaluate the influence of A. baumannii surface virulence factors on the cytotoxicity of OMVs.

In this study, five different A. baumannii strains were used: wild-type clinical isolates (52 wt and 169 wt), previously constructed polysaccharide capsule-deficient mutant strain (52 ΔgalU), outer membrane protein OmpA deficient mutant strain (52 ΔompA), spontaneous mutant strain with lipooligosaccharide (LOS) structural changes (169 ΔLOS). The ompA gene was knocked out of A. baumannii clinical isolate by generating a markerless gene-deletion mutant. The spontaneous mutant strain was obtained by colistin-dependent loss/modification of LOS, evaluated by SDS-PAGE and Alcian Blue dye. The OMVs were purified from each A. baumannii strain by ultracentrifugation of overnight cultures. The concentrations of OMVs were determined by overall protein content detected by Bradford assay. Cytotoxicity of OMVs was evaluated using A549 lung carcinoma epithelial cell line and assessing their viability via the MTT method.

The gene ompA was successfully knocked out from A. baumannii clinical isolate and confirmed by sequencing. Complete loss of LOS in the spontaneous mutant was not observed, but structural modifications were detected. OMVs from all strains exhibited cytotoxicity towards A549 cells compared to the PBS negative control. However, when comparing OMVs from the 52 wt strain and the capsular polysaccharide-nonproducing 52 ΔgalU strain, the latter showed a reduced cytotoxic effect. Similarly, the OMVs from the 169 wt caused lower viability of A549 cells when compared with OMVs from the 169 ΔLOS strain. Therefore, variation in OMV composition causes different outcomes towards cytotoxicity, highlighting the critical contribution of specific surface components to OMV-mediated host cell damage and represent promising targets for future therapeutic interventions.


[1] S. Monem et al., “Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment,” International Journal of Molecular Sciences, vol. 21, no. 15, p. 5498, Jul. 2020, doi: 10.3390/ijms21155498.

[2] E. Tacconelli et al., “Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis,” The Lancet Infectious Diseases, vol. 18, no. 3, pp. 318–327, Dec. 2017, doi: 10.1016/s1473-3099(17)30753-3.

[3] C. M. Harding, S. W. Hennon, and M. F. Feldman, “Uncovering the mechanisms of Acinetobacter baumannii virulence,” Nature Reviews Microbiology, vol. 16, no. 2, pp. 91–102, Dec. 2017, doi: 10.1038/nrmicro.2017.148.

[4] Z. Weng et al., “Outer Membrane Vesicles from Acinetobacter baumannii: Biogenesis, Functions, and Vaccine Application,” Vaccines, vol. 12, no. 1, p. 49, Dec. 2023, doi: 10.3390/vaccines12010049.

[5] B. Cano‐Castaño, M. López‐Siles, F. Nonnoi, A. Pérez, A. C. Lugo, and M. J. McConnell, “Acinetobacter baumannii  as a Model for the Study and Application of Gram‐Negative Outer Membrane Vesicles: A Systematic Review,” Microbial Biotechnology, vol. 18, no. 9, p. e70207, Sep. 2025, doi: 10.1111/1751-7915.70207.